Adagene Net Receivables vs Accounts Payable Analysis

ADAG Stock

USD 2.41 0.08 3.43%

Adagene financial indicator trend analysis is way more than just evaluating Adagene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adagene is a good investment. Please check the relationship between Adagene Net Receivables and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.

Net Receivables vs Accounts Payable

Net Receivables vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Adagene Net Receivables account and Accounts Payable. At this time, the significance of the direction appears to have very week relationship.

The correlation between Adagene's Net Receivables and Accounts Payable is 0.2. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Adagene, assuming nothing else is changed. The correlation between historical values of Adagene's Net Receivables and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Adagene are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Receivables i.e., Adagene's Net Receivables and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.2

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Net Receivables

Accounts Payable

An accounting item on the balance sheet that represents Adagene obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Adagene are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Adagene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adagene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.At this time, Adagene's Enterprise Value Multiple is most likely to increase significantly in the upcoming years.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.9M	2.5M	1.2M	1.6M
Interest Income	76.2K	377.5K	4.3M	4.5M

Depreciation And Amortization Interest Income

Adagene fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		0.67	0.79	0.79	0.88	-0.61	0.86	0.49	0.65	-0.99	-0.81	0.91	0.99	0.32	0.01	0.01	1.0	0.47	0.74	0.8	-0.6	0.85	0.74	-0.42	0.88	0.43
Short Long Term Debt Total	0.67		0.94	0.94	0.66	-0.88	0.68	0.19	0.7	-0.64	-0.91	0.88	0.72	0.2	-0.02	0.04	0.69	-0.22	0.84	0.73	-0.62	0.84	0.76	-0.41	0.72	0.57
Other Current Liab	0.79	0.94		0.96	0.86	-0.74	0.87	0.48	0.71	-0.73	-0.93	0.95	0.79	0.21	0.11	-0.08	0.79	0.07	0.85	0.67	-0.82	0.87	0.91	-0.66	0.9	0.6
Total Current Liabilities	0.79	0.94	0.96		0.79	-0.75	0.79	0.48	0.85	-0.73	-0.88	0.93	0.8	0.27	0.05	-0.02	0.8	0.03	0.77	0.68	-0.72	0.9	0.83	-0.52	0.83	0.45
Total Stockholder Equity	0.88	0.66	0.86	0.79		-0.51	0.99	0.71	0.56	-0.81	-0.82	0.86	0.83	0.1	0.34	-0.32	0.88	0.48	0.68	0.66	-0.9	0.72	0.94	-0.8	1.0	0.59
Other Liab	-0.61	-0.88	-0.74	-0.75	-0.51		-0.57	0.09	-0.43	0.61	0.9	-0.75	-0.69	-0.2	0.11	-0.11	-0.63	0.39	-0.77	-0.86	0.43	-0.72	-0.63	0.15	-0.58	-0.73
Net Tangible Assets	0.86	0.68	0.87	0.79	0.99	-0.57		0.66	0.51	-0.8	-0.85	0.86	0.82	0.09	0.34	-0.32	0.87	0.41	0.71	0.7	-0.91	0.72	0.96	-0.79	1.0	0.67
Property Plant And Equipment Net	0.49	0.19	0.48	0.48	0.71	0.09	0.66		0.5	-0.38	-0.29	0.43	0.37	0.14	0.39	-0.36	0.48	0.62	0.13	0.04	-0.74	0.39	0.63	-0.75	0.68	0.08
Current Deferred Revenue	0.65	0.7	0.71	0.85	0.56	-0.43	0.51	0.5		-0.6	-0.53	0.69	0.64	0.19	0.07	-0.03	0.66	0.18	0.4	0.45	-0.45	0.71	0.51	-0.3	0.59	-0.07
Net Debt	-0.99	-0.64	-0.73	-0.73	-0.81	0.61	-0.8	-0.38	-0.6		0.77	-0.89	-0.99	-0.36	0.09	-0.1	-0.99	-0.47	-0.75	-0.81	0.49	-0.83	-0.65	0.3	-0.81	-0.39
Retained Earnings	-0.81	-0.91	-0.93	-0.88	-0.82	0.9	-0.85	-0.29	-0.53	0.77		-0.93	-0.84	-0.26	-0.02	0.0	-0.82	0.05	-0.89	-0.83	0.73	-0.86	-0.88	0.5	-0.86	-0.79
Accounts Payable	0.91	0.88	0.95	0.93	0.86	-0.75	0.86	0.43	0.69	-0.89	-0.93		0.93	0.4	-0.09	0.11	0.91	0.2	0.91	0.74	-0.7	0.96	0.84	-0.5	0.89	0.56
Cash	0.99	0.72	0.79	0.8	0.83	-0.69	0.82	0.37	0.64	-0.99	-0.84	0.93		0.35	-0.08	0.1	0.99	0.38	0.8	0.84	-0.54	0.88	0.71	-0.34	0.84	0.45
Non Current Assets Total	0.32	0.2	0.21	0.27	0.1	-0.2	0.09	0.14	0.19	-0.36	-0.26	0.4	0.35		-0.83	0.85	0.29	0.02	0.44	-0.02	0.06	0.62	0.06	0.24	0.12	0.02
Non Currrent Assets Other	0.01	-0.02	0.11	0.05	0.34	0.11	0.34	0.39	0.07	0.09	-0.02	-0.09	-0.08	-0.83		-1.0	0.02	0.22	-0.28	0.14	-0.52	-0.32	0.37	-0.64	0.32	0.18
Other Assets	0.01	0.04	-0.08	-0.02	-0.32	-0.11	-0.32	-0.36	-0.03	-0.1	0.0	0.11	0.1	0.85	-1.0		-0.01	-0.22	0.29	-0.14	0.5	0.35	-0.34	0.62	-0.29	-0.19
Cash And Short Term Investments	1.0	0.69	0.79	0.8	0.88	-0.63	0.87	0.48	0.66	-0.99	-0.82	0.91	0.99	0.29	0.02	-0.01		0.46	0.74	0.82	-0.6	0.84	0.75	-0.42	0.89	0.44
Net Receivables	0.47	-0.22	0.07	0.03	0.48	0.39	0.41	0.62	0.18	-0.47	0.05	0.2	0.38	0.02	0.22	-0.22	0.46		0.0	0.03	-0.25	0.11	0.18	-0.37	0.4	-0.22
Common Stock Total Equity	0.74	0.84	0.85	0.77	0.68	-0.77	0.71	0.13	0.4	-0.75	-0.89	0.91	0.8	0.44	-0.28	0.29	0.74	0.0		0.66	-0.54	0.87	0.71	-0.37	0.72	0.66
Common Stock Shares Outstanding	0.8	0.73	0.67	0.68	0.66	-0.86	0.7	0.04	0.45	-0.81	-0.83	0.74	0.84	-0.02	0.14	-0.14	0.82	0.03	0.66		-0.45	0.63	0.64	-0.22	0.7	0.63
Non Current Liabilities Total	-0.6	-0.62	-0.82	-0.72	-0.9	0.43	-0.91	-0.74	-0.45	0.49	0.73	-0.7	-0.54	0.06	-0.52	0.5	-0.6	-0.25	-0.54	-0.45		-0.54	-0.96	0.94	-0.9	-0.65
Other Current Assets	0.85	0.84	0.87	0.9	0.72	-0.72	0.72	0.39	0.71	-0.83	-0.86	0.96	0.88	0.62	-0.32	0.35	0.84	0.11	0.87	0.63	-0.54		0.7	-0.31	0.76	0.43
Other Stockholder Equity	0.74	0.76	0.91	0.83	0.94	-0.63	0.96	0.63	0.51	-0.65	-0.88	0.84	0.71	0.06	0.37	-0.34	0.75	0.18	0.71	0.64	-0.96	0.7		-0.83	0.96	0.74
Total Liab	-0.42	-0.41	-0.66	-0.52	-0.8	0.15	-0.79	-0.75	-0.3	0.3	0.5	-0.5	-0.34	0.24	-0.64	0.62	-0.42	-0.37	-0.37	-0.22	0.94	-0.31	-0.83		-0.78	-0.5
Net Invested Capital	0.88	0.72	0.9	0.83	1.0	-0.58	1.0	0.68	0.59	-0.81	-0.86	0.89	0.84	0.12	0.32	-0.29	0.89	0.4	0.72	0.7	-0.9	0.76	0.96	-0.78		0.62
Property Plant And Equipment Gross	0.43	0.57	0.6	0.45	0.59	-0.73	0.67	0.08	-0.07	-0.39	-0.79	0.56	0.45	0.02	0.18	-0.19	0.44	-0.22	0.66	0.63	-0.65	0.43	0.74	-0.5	0.62

Click cells to compare fundamentals

Adagene Account Relationship Matchups

Adagene fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	105.9M	84.3M	189.5M	152.4M	115.7M	128.7M
Short Long Term Debt Total	2.6M	8.0M	7.5M	28.0M	22.3M	12.9M
Other Current Liab	4.4M	8.6M	16.5M	22.5M	19.7M	14.5M
Total Current Liabilities	7.2M	16.1M	29.8M	55.1M	31.5M	27.5M
Total Stockholder Equity	(57.0M)	(89.4M)	156.6M	83.1M	70.6M	74.1M
Net Tangible Assets	(57.0M)	(89.4M)	156.6M	83.1M	95.6M	100.3M
Property Plant And Equipment Net	1.9M	2.1M	3.5M	3.0M	2.2M	2.8M
Current Deferred Revenue	993.4K	725.5K	5.5M	15.1M	52.9K	50.2K
Net Debt	(90.0M)	(67.2M)	(166.9M)	(115.8M)	(87.6M)	(92.0M)
Retained Earnings	(63.3M)	(105.7M)	(178.8M)	(258.8M)	(277.8M)	(263.9M)
Accounts Payable	712.7K	1.8M	3.3M	3.7M	3.1M	2.4M
Cash	92.5M	75.2M	174.4M	143.8M	109.9M	112.2M
Non Current Assets Total	2.0M	5.2M	3.6M	3.1M	2.3M	3.4M
Non Currrent Assets Other	(109.8K)	(4.1M)	69.3K	109.6K	84.9K	89.1K
Other Assets	87.2K	3.1M	69.3K	109.6K	1.0	0.95
Cash And Short Term Investments	100.5M	75.2M	174.4M	143.8M	109.9M	119.7M
Net Receivables	2.1M	132.4K	7.5M	619.4K	222.0K	210.9K
Common Stock Shares Outstanding	44.2M	35.1M	40.0M	43.3M	43.8M	44.1M
Liabilities And Stockholders Equity	105.9M	84.3M	189.5M	152.4M	115.7M	128.7M
Non Current Liabilities Total	155.7M	157.5M	3.1M	14.2M	13.7M	13.0M
Other Current Assets	1.2M	3.8M	4.1M	4.9M	3.3M	3.4M
Other Stockholder Equity	(147.6M)	(137.8M)	335.5M	342.7M	350.1M	367.6M
Total Liab	162.9M	173.7M	33.0M	69.3M	45.2M	77.3M
Net Invested Capital	(54.5M)	(81.4M)	164.0M	110.9M	92.5M	97.1M
Property Plant And Equipment Gross	1.9M	2.1M	3.5M	3.0M	8.9M	9.4M
Short Long Term Debt	1.0M	5.0M	4.5M	13.6M	8.4M	6.4M
Total Current Assets	103.9M	79.1M	186.0M	149.3M	113.4M	125.3M
Accumulated Other Comprehensive Income	(344.9K)	(351.0K)	(94.0K)	(849.3K)	(1.8M)	(1.7M)
Capital Stock	1.5K	1.9K	5.6K	5.5K	5.5K	4.0K
Net Working Capital	96.7M	63.0M	156.1M	94.2M	82.0M	97.8M
Short Term Debt	1.0M	5.0M	4.5M	13.8M	8.6M	6.5M
Common Stock	1.5K	1.9K	5.6K	5.5K	5.5K	4.0K
Property Plant Equipment	1.9M	2.1M	3.5M	3.0M	3.4M	2.9M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adagene in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adagene's short interest history, or implied volatility extrapolated from Adagene options trading.

Pair Trading with Adagene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adagene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adagene Stock

0.61	VRAX	Virax Biolabs Group Fiscal Year End 12th of June 2024	Pair Corr
0.61	EDSA	Edesa Biotech Financial Report 9th of May 2024	Pair Corr

Moving against Adagene Stock

0.62	INDP	Indaptus Therapeutics Financial Report 9th of May 2024	Pair Corr
0.59	GBIO	Generation BioCo Financial Report 8th of May 2024	Pair Corr
0.47	LIXT	Lixte Biotechnology Earnings Call This Week	Pair Corr
0.44	MOR	MorphoSys AG ADR	Pair Corr
0.42	GLUE	Monte Rosa Therapeutics Earnings Call This Week	Pair Corr

The ability to find closely correlated positions to Adagene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adagene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adagene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adagene to buy it.

The correlation of Adagene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adagene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adagene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Adagene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports:

How To Invest In Adagene

Details

Is Adagene Stock a good investment?

Details

What is Adagene's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.

Note that the Adagene information on this page should be used as a complementary analysis to other Adagene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Adagene Stock analysis

When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.

	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Global Correlations Find global opportunities by holding instruments from different markets
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets

Is Adagene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.44)

Revenue Per Share

0.414

Quarterly Revenue Growth

(0.85)

Return On Assets

(0.11)

Return On Equity

(0.25)

The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Adagene Net Receivables vs Accounts Payable Analysis

Net Receivables vs Accounts Payable

Net Receivables vs Accounts Payable Correlation Analysis

Correlation Coefficient

Net Receivables

Accounts Payable

Adagene fundamental ratios Correlations

Adagene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Adagene fundamental ratios Accounts

Pair Trading with Adagene

Moving together with Adagene Stock

Moving against Adagene Stock

Complementary Tools for Adagene Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Net Tangible Assets
Cash	+ 0.99	Total Assets
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Cash And Short Term Investments	+ 0.99	Cash

Other Assets	- 1.0	Non Currrent Assets Other
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Assets
Other Stockholder Equity	- 0.96	Non Current Liabilities Total
Accounts Payable	- 0.93	Retained Earnings